- Home
- CVAC vs UDMY Comparison
CVAC vs UDMY Comparison
Compare CVAC & UDMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- UDMY
- Stock Information
- Founded
- CVAC 2000
- UDMY 2009
- Country
- CVAC Germany
- UDMY United States
- Employees
- CVAC N/A
- UDMY N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- UDMY Other Consumer Services
- Sector
- CVAC Health Care
- UDMY Real Estate
- Exchange
- CVAC Nasdaq
- UDMY Nasdaq
- Market Cap
- CVAC 1.2B
- UDMY 1.1B
- IPO Year
- CVAC 2020
- UDMY 2021
- Fundamental
- Price
- CVAC $5.41
- UDMY $6.45
- Analyst Decision
- CVAC Hold
- UDMY Buy
- Analyst Count
- CVAC 3
- UDMY 10
- Target Price
- CVAC $6.83
- UDMY $9.89
- AVG Volume (30 Days)
- CVAC 404.4K
- UDMY 1.8M
- Earning Date
- CVAC 11-11-2025
- UDMY 10-28-2025
- Dividend Yield
- CVAC N/A
- UDMY N/A
- EPS Growth
- CVAC N/A
- UDMY N/A
- EPS
- CVAC 1.01
- UDMY N/A
- Revenue
- CVAC $599,540,810.00
- UDMY $795,538,000.00
- Revenue This Year
- CVAC N/A
- UDMY $2.58
- Revenue Next Year
- CVAC $23.83
- UDMY $4.19
- P/E Ratio
- CVAC $5.40
- UDMY N/A
- Revenue Growth
- CVAC 675.15
- UDMY 3.93
- 52 Week Low
- CVAC $2.37
- UDMY $5.68
- 52 Week High
- CVAC $5.72
- UDMY $10.61
- Technical
- Relative Strength Index (RSI)
- CVAC 53.41
- UDMY 34.92
- Support Level
- CVAC $5.33
- UDMY $6.88
- Resistance Level
- CVAC $5.45
- UDMY $6.98
- Average True Range (ATR)
- CVAC 0.03
- UDMY 0.24
- MACD
- CVAC 0.01
- UDMY -0.06
- Stochastic Oscillator
- CVAC 66.10
- UDMY 1.74
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About UDMY Udemy Inc.
Udemy Inc operates a marketplace platform at the center of a vibrant knowledge network. The company operates under two operating and reportable segments Consumer and Enterprise, out of which the Enterprise segment derives the maximum revenue. Geographically, the company derives maximum revenue from North America. The company leverages data, technology, and insights for effective learning experiences. It helps individuals and organizations to possess effective skill acquisition and development with flexibility.